| Literature DB >> 31443182 |
Sihao Gu1, Ling Li1, Hai Huang2, Bing Wang3,4, Tong Zhang5.
Abstract
Atractylodes macrocephala Koidz. has been used as an invigorating spleen drug for eliminating dampness and phlegm in China. According to recent researches, different processing methods may affect the drug efficacy, so we collected A. macrocephala from the Zhejiang Province, produced with different processing methods, crude A. macrocephala (CA) and bran-processed A. macrocephala (BA), then analyzed its essential oils (EOs) by GC/MS. The results showed 34 components representing 98.44% of the total EOs of CA were identified, and 46 components representing 98.02% of the total EOs of BA were identified. Atractylone is the main component in A. macrocephala. Compared with CA, BA has 46 detected compounds, 28 of which were identical, and 6 undetected compounds. Pharmacodynamic results revealed that the EOs of CA and atractylone exhibited more effective anticancer activity in HepG2, MCG803, and HCT-116 cells than the EOs of BA; while the EOs of BA exhibited simple antiviral effect on viruses H3N2, both the EOs and atractylone show anti-inflammatory activity by inhibiting the lipopolysaccharide (LPS)-induced nitric oxide (NO) production in ANA-1 cells.Entities:
Keywords: Atractylodes macrocephala Koidz.; GC/MS; atractylone; essential oils; pharmacodynamic effect; processing methods
Mesh:
Substances:
Year: 2019 PMID: 31443182 PMCID: PMC6719198 DOI: 10.3390/molecules24162956
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1The relevance of chemical compositions in the EOs produced from A. macrocephala and biological activities.
Figure 2GC/MS chromatograms of the EOs of A. macrocephala. (A) GC/MS chromatograms of the EOs of crude A. macrocephala (CA); (B) GC/MS chromatograms of the EOs of bran-processed A. macrocephala (BA).
Chemical compositions and content * of the EOs of CA and BA.
| No. | Retention (min) | Compounds | Molecular Formula | EOs of CA | EOs of BA | CAS No. | Reference | ||
|---|---|---|---|---|---|---|---|---|---|
| Area (%) | Similarity | Area (%) | Similarity | ||||||
| 1 | 21.085 | α-Guaiene | C15H24 | ND | 0.13 | 87.5 | 3691-12-1 | [ | |
| 2 | 22.327 | α-Amylcinnamyl alcohol | C14H20O | 0.35 | 87.8 | 0.29 | 87.9 | 101-85-9 | [ |
| 3 | 22.561 | Berkheyaradulene | C15H24 | 0.54 | 87.8 | 0.42 | 87.7 | 65372-78-3 | [ |
| 4 | 22.769 | Eremophylene | C15H24 | ND | 0.15 | 83.7 | 10219-75-7 | [ | |
| 5 | 22.987 | α-Gurjunene | C15H24 | 0.48 | 93.1 | 0.97 | 92.8 | 489-40-7 | [ |
| 6 | 23.189 | β-Isocomene | C15H24 | ND | 0.26 | 71.1 | 74311-15-2 | [ | |
| 7 | 23.236 | (−)-β-Caryophyllene | C15H24 | ND | 0.28 | 70 | 87-44-5 | [ | |
| 8 | 23.674 | Isoledene | C15H24 | 1.85 | 96.3 | 1.75 | 96.3 | 95910-36-4 | [ |
| 9 | 24.135 | γ-Elemene | C15H24 | 0.64 | 93.5 | 1.14 | 93.7 | 29873-99-2 | [ |
| 10 | 24.753 | α-Caryophyllene | C15H24 | 1.21 | 92.5 | 1.07 | 92.5 | 6753-98-6 | [ |
| 11 | 25.622 | 1,2,3,4,4a,7-Hexahydro-1,6-dimethyl-4-(1-methylethyl)naphthalene | C15H24 | 0.33 | 81.1 | 0.34 | 83.2 | 16728-99-7 | [ |
| 12 | 25.850 | Cedrol | C15H26O | ND | 0.14 | 51.6 | 77-53-2 | [ | |
| 13 | 25.864 | β-Selinene | C15H24 | 4.88 | 95.4 | 4.36 | 95.3 | 17066-67-0 | [ |
| 14 | 26.085 | trans-Nuciferol | C15H22O | 0.69 | 76 | 0.67 | 78.6 | 39599-18-3 | [ |
| 15 | 26.829 | Calarene | C15H24 | 0.84 | 91.5 | 0.74 | 91.7 | 17334-55-3 | [ |
| 16 | 27.136 | Zingiberene | C15H24 | 0.33 | 76.1 | 0.25 | 65.8 | 495-60-3 | [ |
| 17 | 27.441 | (−)-Norbornenone | C7H8O | 1.06 | 57.5 | ND | 16620-79-4 | [ | |
| 18 | 27.459 | 1,2,3,6-Tetramethylbicyclo[2.2.2] octa-2,5-diene | C12H18 | 1.68 | 58.5 | ND | 62338-43-6 | [ | |
| 19 | 27.486 | 2-Methoxy-4-methyl-1-(1-methylethyl)benzene | C11H16O | ND | 0.55 | 60.9 | 1076-56-8 | [ | |
| 20 | 27.486 | 3,7-Guaiadiene | C15H24 | 9.57 | 75.7 | ND | 6754-04-7 | [ | |
| 21 | 27.497 | Eudesma-4(14),11-diene | C15H24 | 5.34 | 72.6 | 5.38 | 70.2 | 17066-67-0 | [ |
| 22 | 27.500 | 1-Heptanal | C7H14O | ND | 1.74 | 57.9 | 111-71-7 | [ | |
| 23 | 27.507 | 1-Adamantylethanol | C12H20O | ND | 3.66 | 61.4 | 6240-11-5 | [ | |
| 24 | 27.519 | 2-Phenylacetamide | C8H9NO | ND | 6.32 | 64.3 | 103-81-1 | [ | |
| 25 | 27.674 | Eudesma-3,7(11)-diene | C15H24 | 5.57 | 80.6 | 4.36 | 79.6 | 6813-21-4 | [ |
| 26 | 27.708 | Caryophyllene | C15H24 | 0.57 | 61.9 | ND | 87-44-5 | [ | |
| 27 | 27.721 | β-Himachalene | C15H24 | ND | 0.19 | 61.4 | 1461-03-6 | [ | |
| 28 | 27.723 | Isolongifolene | C15H24 | 4.33 | 81.3 | 3.04 | 75.9 | 1135-66-6 | [ |
| 29 | 27.732 | β-Eudesmol | C15H26O | ND | 0.77 | 54.3 | 473-15-4 | [ | |
| 30 | 27.738 | C7H12O | ND | 0.21 | 61.8 | 18829-55-5 | [ | ||
| 31 | 27.756 | (9E,12E)-9,12-Octadecadienoic acid methylester | C19H34O2 | ND | 0.41 | 76.8 | 2566-97-4 | [ | |
| 32 | 28.089 | γ-Gurjunene | C15H24 | 1.31 | 95 | 4.37 | 94.6 | 22567-17-5 | [ |
| 33 | 28.297 | Aromadendrene | C15H24 | 3.23 | 91.1 | 3.29 | 91.9 | 489-39-4 | [ |
| 34 | 29.978 | β-Vatirenene | C15H22 | 0.37 | 78.5 | 0.35 | 77.4 | 27840-40-0 | [ |
| 35 | 31.173 | Atractylone | C15H20O | 41.92 | 95 | 23.77 | 95 | 6989-21-5 | [ |
| 36 | 31.239 | ( | C10H20O | ND | 8.99 | 78.2 | 10340-22-4 | [ | |
| 37 | 31.514 | Agarospirol | C15H26O | ND | 6.25 | 77.9 | 1460-73-7 | [ | |
| 38 | 31.559 | β-Elemene | C15H24 | 0.25 | 79 | ND | 515-13-9 | [ | |
| 39 | 31.616 | 4,11,11-Trimethyl-8-methylenebicyclo[7.2.0] undec-4-ene | C15H24 | ND | 0.16 | 80.3 | 13877-93-5 | [ | |
| 40 | 32.066 | 10S,11S-Himachala-3(12),4-diene | C15H24 | 1.54 | 94.3 | 1.38 | 94.4 | 60909-28-6 | [ |
| 41 | 32.611 | Dehydroaromadendrene | C15H22 | 0.29 | 81.5 | 0.24 | 83.1 | 698388-95-3 | [ |
| 42 | 33.039 | 4,5-Dehydroisolongifolene | C15H22 | ND | 0.45 | 79.5 | 1246777-02-5 | [ | |
| 43 | 33.072 | Aristolone | C15H22O | 2.69 | 87.1 | 3.58 | 82.7 | 6831-17-0 | [ |
| 44 | 33.283 | 3,7,11-Trimethyl-dodeca-2,4,6,10-tetraenal | C15H22O | 0.34 | 78.2 | 0.28 | 81.2 | 13832-89-8 | [ |
| 45 | 33.865 | Spathulenol | C15H24O | 0.34 | 76.7 | ND | 6750-60-3 | [ | |
| 46 | 33.874 | 3,4,7,8-Tetrahydro-8,8,9,9-tetramethyl-2H-2,4a-methanonaphthalene | C15H22 | ND | 0.25 | 77.9 | 67517-14-0 | [ | |
| 47 | 36.250 | Velleral | C15H20O2 | 1.02 | 85.3 | 0.70 | 84.2 | 50656-61-6 | [ |
| 48 | 37.741 | α-Curcumene | C15H22 | 3.65 | 89.2 | 3.95 | 88.8 | 644-30-4 | [ |
| 49 | 39.958 | Procerin | C15H18O2 | 0.83 | 72.3 | 0.67 | 74.2 | 552-96-5 | [ |
| 50 | 40.439 | 8,9-dehydro-9-formyl-Cycloisolongifolene | C16H22O | 0.31 | 69 | 0.25 | 68.8 | 1206188-76-2 | [ |
| 51 | 41.022 | 3a,5,6,7,8,8a,9,9a-Octahydro-5,8a-dimethyl-3-methylenenaphtho[2-b]furan-2(3 | C15H20O2 | 0.72 | 89.8 | 0.36 | 89.4 | 80367-94-8 | [ |
| 52 | 41.861 | 1,2,3,3a,4,5-Hexahydro-1,1,4,4-tetramethyl-2,3b-methano-3bH-cyclopenta[1,3]cyclopropa[1,2]benzene-6-carboxaldehyde | C16H22O | 0.23 | 68.7 | 0.13 | 67.9 | 59820-24-5 | [ |
| Total | 98.44 | 98.02 | |||||||
* ND = Not Detected.
Figure 3Inhibition of proliferation of HepG2, MCG803, and HCT-116 cells by atractylone, the EOs of CA and the EOs of BA (n = 3).
Figure 4(A) Effects of EOs of CA, EOs of BA, and atractylone on the viability of ANA-1 cells (n = 3). cell: blank control; cell + EOs of CA, EOs of BA and atractylone: EOs of CA, EOs of BA and atractylone at 50 μg·mL−1 respectively. (B) NO inhibitory effects of EOs of CA, EOs of BA and atractylone on LPS-activated ANA-1 cells (n = 3). cell: blank control; DMSO: DMSO at the concentrations of 1:2500; LPS: LPS control; DEX: positive control of DEX at 10 μg·mL−1; EOs of CA, EOs of BA and atractylone: EOs of CA, EOs of BA and atractylone at 50 μg·mL−1 respectively; ***: p < 0.001 vs. LPS.